Omnicell delivers strong fourth quarter financial results. Results exceed previously issued full year guidance for bookings, total revenues, and non-GAAP EBITDA. FORT WORTH, Texas ...
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Omnicell (OMCL – Research Report). The company’s shares ...
The market expects Omnicell (OMCL) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2024. This widely-known consensus ...
Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the 43rd Annual J.P. Morgan Healthcare Conference on Wednesday, January ...
FORT WORTH, Texas--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy and nursing care delivery model, will release its financial results for the fourth quarter ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results